e-learning
resources
Barcelona 2010
Wednesday, 22.09.2010
Comorbidities and disease management in primary care
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
GOLD Stage I and II patients in European Health-related Quality of Life in COPD study
P. W. Jones, T. van der Molen, P. Kardos, G. Nadeau, L. Adamek, N. Banik (United Kingdom; Groningen, Netherlands; Frankfurt, Munich, Germany; Marly le Roi, France)
Source:
Annual Congress 2010 - Comorbidities and disease management in primary care
Session:
Comorbidities and disease management in primary care
Session type:
E-Communication Session
Number:
5459
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
P. W. Jones, T. van der Molen, P. Kardos, G. Nadeau, L. Adamek, N. Banik (United Kingdom; Groningen, Netherlands; Frankfurt, Munich, Germany; Marly le Roi, France). GOLD Stage I and II patients in European Health-related Quality of Life in COPD study. Eur Respir J 2010; 36: Suppl. 54, 5459
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Primary care physician assessment of COPD severity: European Health-related Quality of Life in COPD study
Source: Annual Congress 2010 - From diagnosis to disease management in primary care
Year: 2010
Relationship between co-morbidities and patient-reported health status in the European Health-related Quality of Life in COPD study
Source: Annual Congress 2010 - Comorbidities and disease management in primary care
Year: 2010
Comparison of demographic data of patients with COPD treated in primary care by country in European Health-related Quality of Life in COPD study
Source: Annual Congress 2010 - From diagnosis to disease management in primary care
Year: 2010
Quality of life, stage severity and COPD
Source: Eur Respir J 2009; 33: 953-955
Year: 2009
COPD severity using GOLD 2017 in real life: The French Palomb Cohort
Source: International Congress 2017 – COPD: from screening to risk factors of lung cancer
Year: 2017
Adherence to GOLD guidelines and health-related quality of life in outpatients with COPD
Source: Annual Congress 2009 - Healthcare and treatment of COPD
Year: 2009
Quality of life in patients with IPF in Australia
Source: International Congress 2016 – Interstitial lung disease registry
Year: 2016
Quality of life (QoL) in patients with stage IIIB NSCLC: Personal evaluation
Source: Eur Respir J 2002; 20: Suppl. 38, 271s
Year: 2002
Characterization of patients with COPD GOLD stage I and II referred for pulmonary rehabilitation
Source: International Congress 2015 – Latest insights into chronic care
Year: 2015
Quality of life in the PLATINO study 6 to 9 years later
Source: International Congress 2015 – Latest insights into the management of chronic respiratory diseases
Year: 2015
Effectiveness of a 3-week-in-patient-rehabilitation-program in patients with COPD GOLD-stage IV
Source: Annual Congress 2013 –The latest insights in pulmonary rehabilitation (part 1)
Year: 2013
Quality of life estimates in the Sheffield COPD study
Source: Annual Congress 2009 - Air pollution and other exposures
Year: 2009
Quality of life (QOL) and clinical phenotypes in COPD
Source: Eur Respir J 2006; 28: Suppl. 50, 809s
Year: 2006
Quality of life in COPD patients with sarcopenia.
Source: International Congress 2019 – Hot topics in assessment and care for chronic lung diseases
Year: 2019
Factors associated with quality of life measured by EQ-5D in Korean COPD patients
Source: Annual Congress 2013 –Quality of life and respiratory symptoms in primary care COPD populations
Year: 2013
LATE-BREAKING ABSTRACT: GOLD 2011: Combined COPD assessment of patients from the European health-related quality of life study
Source: Annual Congress 2012 - GOLD guidelines 2011: new assessment of COPD
Year: 2012
Does panic predict health-related quality of life (HRQoL) in COPD? A longitudinal cohort study
Source: International Congress 2014 – Respiratory disease management in primary care
Year: 2014
Predictive role of mMRC scale on quality of life in COPD patients
Source: Annual Congress 2013 –The latest insights in pulmonary rehabilitation (part 2)
Year: 2013
Quality of life in patients with COPD. Results of EPIDEPOC study
Source: Eur Respir J 2005; 26: Suppl. 49, 718s
Year: 2005
Development and validation of the Adolescent Asthma Quality of Life Questionnaire (AAQOL)
Source: Eur Respir J 2001; 17: 52-58
Year: 2001
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept